1-7 of 7
Holly Yin
Close
Sort by
Journal Articles

A Synthetic Lethality Druggable Genome RNAi Screen Identifies Genes Mediating Sensitivity To Lenalidomide In Multiple Myeloma Including RSK2

Yuan Xiao Zhu, Ph.D., Laura Bruins, Chang-Xin Shi, Ph.D., Jessica Schmidt, Chris Sereduk, Mia Champion, Ph.D., Esteban Braggio, Ph.D., Holly Yin, Ph.D., A. Keith Stewart, MBChB
Journal: Blood
Blood (2013) 122 (21): 3084.
https://doi.org/10.1182/blood.V122.21.3084.3084
Published: 2013
Journal Articles

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Yuan Xiao Zhu, Rodger Tiedemann, Chang-Xin Shi, Holly Yin, Jessica E. Schmidt, Laura A. Bruins, Jonathan J. Keats, Esteban Braggio, Chris Sereduk, Spyro Mousses, A. Keith Stewart
Journal: Blood
Blood (2011) 117 (14): 3847–3857.
https://doi.org/10.1182/blood-2010-08-304022
Published: 2011
Includes: Supplemental data
Journal Articles

Phosphatase RNA-Interference Lethality Screening with Suberoylanilide Hyrdoxamic Acid In Myeloid Cell Lines

James Bogenberger, Michelle Kassner, Donald Chow, Holly Yin, Raoul Tibes
Journal: Blood
Blood (2010) 116 (21): 1851.
https://doi.org/10.1182/blood.V116.21.1851.1851
Published: 2010
Journal Articles

Phosphatome and Kinome RNAi Screen In Leukemia

Raoul Tibes, James Bogenberger, Donald Chow, Irma Gonzales, David Azorsa, Holly Yin
Journal: Blood
Blood (2010) 116 (21): 180.
https://doi.org/10.1182/blood.V116.21.180.180
Published: 2010
Journal Articles

RNAi Screen of the Druggable Genome Identifies Modulators of Proteasome Inhibitor Sensitivity in Myeloma Including CDK5.

Yuan Xiao Zhu, PhD, Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Chang-Xin Shi, PhD, Jessica Schmidt, BS, Laura Bruins, Jonathan J Keats, PhD, Holly Yin, PhD, Chris Sereduk, Spyro Mousses, PhD, A. Keith Stewart, MBChB
Journal: Blood
Blood (2009) 114 (22): 602.
https://doi.org/10.1182/blood.V114.22.602.602
Published: 2009
Journal Articles

Kinome and Druggable Genome Vulnerabilities in Multiple Myeloma Identified by Systematic RNA Interference Screening.

Rodger E. Tiedemann, MD, PhD, Yuan-Xiao Zhu, PhD, Holly Yin, PhD, Quick Que, PhD, Chang-Xin Shi, PhD, Spyro Mousses, PhD, Keith Stewart, MD
Journal: Blood
Blood (2007) 110 (11): 391.
https://doi.org/10.1182/blood.V110.11.391.391
Published: 2007
Journal Articles

RNAi Screen of the Druggable Genome To Identify Modulators of Bortezomib in Myeloma.

Yuan Xiao Zhu, PhD, Holly Yin, Ph.D., Qiang Que, Ph.D., Rodger E. Tiedemann, M.D., Ph.D., Wee-Joo Chng, M.D., Chang Xin Shi, Ph.D., Spyro Mousses, Ph.D, Keith Stewart, M.D
Journal: Blood
Blood (2007) 110 (11): 2478.
https://doi.org/10.1182/blood.V110.11.2478.2478
Published: 2007